Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06926855 · ClinicalTrials.gov registry record · NA

Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.

A NA study of Uncontrolled Hypertension and Uncontrolled Diabetes, sponsored by Morehouse School of Medicine.

Active
Registry status
NA
Development phase
3,120
Enrollment target
3
Study locations

NCT06926855: Active NA study of Uncontrolled Hypertension and Uncontrolled Diabetes, sponsored by Morehouse School of Medicine.

NCT06926855 is a NA study of Uncontrolled Hypertension and Uncontrolled Diabetes that is active but no longer recruiting, run by Morehouse School of Medicine. The registered enrollment target is 3,120 participants, above the 452-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (590% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06926855, a NA study of Uncontrolled Hypertension and Uncontrolled Diabetes, is active but no longer recruiting, sponsored by Morehouse School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,120 participants
Enrollment target
3
Study locations

Study Summary

The goal of this mixed-methods study is to assess the impact of a Community Health Worker (CHW)-led social risk screening and referral in improving management of uncontrolled diabetes (DM) and hypertension (HTN) among patients receiving care in community health centers (CHCs or health centers). The intervention is focused on adult health center patients with uncontrolled DM and/or HTN. Study findings will provide important evidence to guide CHCs in implementing programs to address social risks in their patient populations. Findings will illuminate whether and how CHW-led interventions to address social needs yield the hypothesized outcomes. The aims of the study are: * AIM 1: Measure how effective the CHW-led social risk program is at reducing blood sugar levels (A1C) in CHC patients with uncontrolled DM and lowering blood pressure in CHC patients with uncontrolled HTN. * AIM 2: Identify effective strategies for increasing and expanding CHW-led social risk programs.

Primary Outcome

Percentage of participants with a clinically significant improvement in HbA1c, defined as ≥0.5% improvement in HbA1c

Interventions

  • OTHER CHC-level cluster randomized control trial

Study Locations (3)

Florida

  • Health Choice Network (HCN) - Miami

Georgia

  • Morehouse School of Medicine - Atlanta

Oregon

  • OCHIN - Portland

Trial Details

FieldValue
Enrollment Target 3,120 participants
Start Date 2025-05-01
Est. Completion 2026-06-30
Phase NA
Morehouse School of Medicine

13 total trials

What the registry record for NCT06926855 still lists

NCT06926855 is an interventional study that assigns participants to a tested intervention. Its 3,120 participants enrollment target places it among the larger protocols in the corpus, above the 452-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (590% higher).

The record links to 2 conditions, with Uncontrolled Hypertension appearing as the primary indexed condition, and to 1 intervention - of which CHC-level cluster randomized control trial is the first listed.

NCT06926855 reports a single indexed study location in Florida, Georgia, Oregon.

Frequently Asked Questions

What is clinical trial NCT06926855 about?

NCT06926855 is a clinical study titled "Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.". The goal of this mixed-methods study is to assess the impact of a Community Health Worker (CHW)-led social risk screening and referral in improving management of uncontrolled diabetes (DM) and hypertension (HTN) among patients receiving care in community health centers (CHCs or health centers). The ...

What is the current status of trial NCT06926855?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,120 participants. The study started on 2025-05-01. Estimated completion is 2026-06-30.

What conditions does trial NCT06926855 study?

This clinical trial studies the following conditions: Uncontrolled Hypertension, Uncontrolled Diabetes.

What interventions are being tested in trial NCT06926855?

The interventions under investigation include: CHC-level cluster randomized control trial (OTHER).

Who is sponsoring clinical trial NCT06926855?

This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06926855 being conducted?

This trial has 3 study locations across Florida, Georgia, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Uncontrolled Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06926855's enrollment target sits among peer trials

3,120 1st of 10 higher than 10 of 10 other Uncontrolled Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Uncontrolled Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05051722 · 3,110 participants

    Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • NCT04722822 · 3,100 participants · NA

    The HPV 9-10 Trial: Early Initiation of HPV Vaccination

  • NCT06224205 · 3,150 participants · NA

    Digital Detection of Dementia (D Cubed) Studies: D3

  • NCT05534243 · 3,090 participants · NA

    The ED-AWARENESS-2 Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06926855, the US trial registry maintained by the National Library of Medicine. NCT06926855 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.